Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 3
2009 1
2010 1
2011 1
2016 1
2018 1
2020 3
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Growth hormone treatment of Canadian children: results from the GeNeSIS phase IV prospective observational study.
Deal C, Kirsch S, Chanoine JP, Lawrence S, Cummings E, Rosolowsky ET, Marks SD, Jia N, Child CJ; GeNeSIS National Board on behalf of the GeNeSIS Canada Investigators. Deal C, et al. Among authors: rosolowsky et. CMAJ Open. 2018 Sep 10;6(3):E372-E383. doi: 10.9778/cmajo.20180020. Print 2018 Jul-Sep. CMAJ Open. 2018. PMID: 30201821 Free PMC article.
Risk for ESRD in type 1 diabetes remains high despite renoprotection.
Rosolowsky ET, Skupien J, Smiles AM, Niewczas M, Roshan B, Stanton R, Eckfeldt JH, Warram JH, Krolewski AS. Rosolowsky ET, et al. J Am Soc Nephrol. 2011 Mar;22(3):545-53. doi: 10.1681/ASN.2010040354. Epub 2011 Feb 25. J Am Soc Nephrol. 2011. PMID: 21355053 Free PMC article.
High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up.
Ficociello LH, Rosolowsky ET, Niewczas MA, Maselli NJ, Weinberg JM, Aschengrau A, Eckfeldt JH, Stanton RC, Galecki AT, Doria A, Warram JH, Krolewski AS. Ficociello LH, et al. Among authors: rosolowsky et. Diabetes Care. 2010 Jun;33(6):1337-43. doi: 10.2337/dc10-0227. Epub 2010 Mar 23. Diabetes Care. 2010. PMID: 20332356 Free PMC article.
11 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page